Literature DB >> 8473446

Management of suboptimal sonographic endometrial patterns in patients undergoing in-vitro fertilization and embryo transfer.

G Sher1, S Dodge, G Maassarani, V Knutzen, C Zouves, M Feinman.   

Abstract

A total of 816 women who underwent 1332 cycles of ovarian stimulation for in-vitro fertilization and embryo transfer (IVF/ET) had sonographic assessments of the endometrium within 2 days of oocyte retrieval. Endometrial linings were classified on the basis of thickness and echogenicity, using a grading system described previously. Grades I and IIB ('poor') were associated with a 6% viable pregnancy rate (advanced beyond 12 weeks' gestation) compared with a 29% rate for Grade IIA ('optimal'). In a subset of 112 women with poor endometrial linings during natural cycles, eight out of 21 women (38%) under 40 years of age developed optimal linings following ovarian stimulation with menotrophins, while 19 out of 91 women (21%) aged 41-45 years converted to optimal linings. Twenty-two out of 47 women (44%) who failed to develop optimal endometrial linings following ovarian stimulation converted to Grade IIA during subsequent cycles of exogenous oestrogen replacement. The financial, emotional, and physical burden associated with IVF/ET demands that patients with poor endometrial linings following ovarian stimulation with menotrophins be counselled with regard to either cancelling their cycles of treatment, or having their embryos cryopreserved for transfer to the uterus during a subsequent hormonal replacement cycle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473446     DOI: 10.1093/oxfordjournals.humrep.a138049

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Endometrial pattern on the day of oocyte retrieval is more predictive of implantation success than the pattern or thickness on the day of hCG administration.

Authors:  F I Sharara; J Lim; H D McClamrock
Journal:  J Assist Reprod Genet       Date:  1999-11       Impact factor: 3.412

2.  Power Doppler endometrial evaluation as a method for the prognosis of embryo implantation in an ICSI program.

Authors:  P Contart; R L Baruffi; J Coelho; A L Mauri; C Petersen; J G Franco Júnior
Journal:  J Assist Reprod Genet       Date:  2000-07       Impact factor: 3.412

3.  Development and validation of a pregnancy prediction model based on ultrasonographic features related to endometrial receptivity.

Authors:  Xujuan Shui; Caicha Yu; Jianxin Li; Yan Jiao
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate.

Authors:  Hanan Refai; Doaa Hassan; Rehab Abdelmonem
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  A meta-analysis of the relationship between endometrial thickness and outcome of in vitro fertilization cycles.

Authors:  Mazdak Momeni; Mohammad H Rahbar; Ertug Kovanci
Journal:  J Hum Reprod Sci       Date:  2011-09

6.  The predictive value of serial serum estradiol and serial endometrial volume on endometrial receptivity on assisted reproductive technology cycles.

Authors:  R Silva Martins; A Helio Oliani; D Vaz Oliani; J Martinez de Oliveira
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-05       Impact factor: 3.007

7.  The Effect of Vaginal Sildenafil on The Outcome of Assisted Reproductive Technology Cycles in Patients with Repeated Implantation Failures: A Randomized Placebo-Controlled Trial.

Authors:  Ashraf Moini; Fatemeh Zafarani; Nadia Jahangiri; S Hahideh Jahanian Sadatmahalleh; Marya Sadeghi; Mohammad Chehrazi; Firoozeh Ahmadi
Journal:  Int J Fertil Steril       Date:  2019-11-11

8.  Continuous endometrial volumetric analysis for endometrial receptivity assessment on assisted reproductive technology cycles.

Authors:  Renato Silva Martins; António Helio Oliani; Denise Vaz Oliani; José Martinez de Oliveira
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-03       Impact factor: 3.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.